Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03352908 · ClinicalTrials.gov registry record
Yale Swallow Protocol in Extubated Patients
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 166
- Enrollment target
NCT03352908: Completed study, sponsored by University of Wisconsin, Madison.
NCT03352908 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 166 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03352908 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 166 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the Yale Swallow Protocol is an effective screen for aspiration in recently extubated patients.
Primary Outcome
Participants will receive FEES and YSP in a randomized order within a 2 hours of one another. Sensitivity estimates and analysis will be obtained through confidence intervals
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2017-10-25 |
| Est. Completion | 2020-10-29 |
What the finished NCT03352908 record still lists
NCT03352908 is an observational study that tracks outcomes without assigning an intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03352908 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03352908 about?
NCT03352908 is a clinical study titled "Yale Swallow Protocol in Extubated Patients". The purpose of this study is to determine if the Yale Swallow Protocol is an effective screen for aspiration in recently extubated patients.
What is the current status of trial NCT03352908?
This trial is currently completed. The enrollment target is 166 participants. The study started on 2017-10-25. Estimated completion is 2020-10-29.
Who is sponsoring clinical trial NCT03352908?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747303 · 166 participants · Phase 2
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- NCT03806283 · 166 participants
Mechanisms of Pregnancy Vascular Adaptations
- NCT04040452 · 166 participants · Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- NCT04375813 · 166 participants · Phase 2
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI